| Detection and localization of surgically resectable cancers with a multi-analyte blood test JD Cohen, L Li, Y Wang, C Thoburn, B Afsari, L Danilova, C Douville, ... Science 359 (6378), 926-930, 2018 | 2386 | 2018 |
| Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer J Tie, Y Wang, C Tomasetti, L Li, S Springer, I Kinde, N Silliman, M Tacey, ... Science translational medicine 8 (346), 346ra92-346ra92, 2016 | 1386 | 2016 |
| Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention C Tomasetti, L Li, B Vogelstein Science 355 (6331), 1330-1334, 2017 | 1197 | 2017 |
| Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers JD Cohen, AA Javed, C Thoburn, F Wong, J Tie, P Gibbs, CM Schmidt, ... Proceedings of the National Academy of Sciences 114 (38), 10202-10207, 2017 | 536 | 2017 |
| Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer J Tie, JD Cohen, Y Wang, M Christie, K Simons, M Lee, R Wong, ... JAMA oncology 5 (12), 1710-1717, 2019 | 500 | 2019 |
| Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study J Tie, JD Cohen, Y Wang, L Li, M Christie, K Simons, H Elsaleh, ... Gut 68 (4), 663-671, 2019 | 294 | 2019 |
| Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers Y Wang, L Li, C Douville, JD Cohen, TT Yen, I Kinde, K Sundfelt, SK Kjær, ... Science translational medicine 10 (433), eaap8793, 2018 | 215 | 2018 |
| Prognostic potential of circulating tumor DNA measurement in postoperative surveillance of nonmetastatic colorectal cancer Y Wang, L Li, JD Cohen, I Kinde, J Ptak, M Popoli, J Schaefer, N Silliman, ... JAMA oncology 5 (8), 1118-1123, 2019 | 181 | 2019 |
| Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer B Lee, L Lipton, J Cohen, J Tie, AA Javed, L Li, D Goldstein, M Burge, ... Annals of Oncology 30 (9), 1472-1478, 2019 | 170 | 2019 |
| Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy SU Springer, CH Chen, MDC Rodriguez Pena, L Li, C Douville, Y Wang, ... Elife 7, e32143, 2018 | 159 | 2018 |
| A multimodality test to guide the management of patients with a pancreatic cyst S Springer, DL Masica, M Dal Molin, C Douville, CJ Thoburn, B Afsari, L Li, ... Science translational medicine 11 (501), eaav4772, 2019 | 142 | 2019 |
| Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study J Tie, Y Wang, J Cohen, L Li, W Hong, M Christie, HL Wong, S Kosmider, ... PLoS medicine 18 (5), e1003620, 2021 | 115 | 2021 |
| Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies J Tie, JD Cohen, SN Lo, Y Wang, L Li, M Christie, M Lee, R Wong, ... International journal of cancer 148 (4), 1014-1026, 2021 | 84 | 2021 |
| Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology MDC Rodriguez Pena, SU Springer, D Taheri, L Li, AC Tregnago, ... Virchows Archiv 476, 423-429, 2020 | 40 | 2020 |
| Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC). J Tie, J Cohen, Y Wang, M Lee, R Wong, S Kosmider, S Ananda, JH Cho, ... Journal of Clinical Oncology 36 (15_suppl), 3516-3516, 2018 | 26 | 2018 |
| The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations R Wong, J Tie, M Lee, J Cohen, Y Wang, L Li, S Ma, M Christie, ... International journal of cancer 145 (2), 540-547, 2019 | 21 | 2019 |
| Potential role of circulating tumor DNA (ctDNA) in the early diagnosis and post-operative management of localised pancreatic cancer. B Lee, J Cohen, LR Lipton, J Tie, AA Javed, L Li, D Goldstein, P Cooray, ... Journal of Clinical Oncology 35 (15_suppl), 4101-4101, 2017 | 17 | 2017 |
| Supervised mutational signatures for obesity and other tissue-specific etiological factors in cancer B Afsari, A Kuo, YF Zhang, L Li, K Lahouel, L Danilova, A Favorov, ... Elife 10, e61082, 2021 | 16 | 2021 |
| The potential of circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy decision making in locally advanced rectal cancer (LARC). J Tie, J Cohen, Y Wang, L Li, I Kinde, H Elsaleh, R Wong, S Kosmider, ... Journal of Clinical Oncology 35 (15_suppl), 3521-3521, 2017 | 14 | 2017 |
| The potential of circulating tumor DNA (ctDNA) to reshape the design of clinical trials testing adjuvant therapy in patients with early stage cancers. J Tie, Y Wang, C Tomasetti, L Li, S Springer, I Kinde, R Wong, S Kosmider, ... Journal of Clinical Oncology 34 (15_suppl), 3511-3511, 2016 | 10 | 2016 |
Bert VogelsteinJohns HopkinsVerified email at jhmi.edu
